REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.50
-0.26 (-3.35%)
Oct 6, 2026, 1:12 PM EDT - Market open
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $495.1 million as of October 6, 2026. Its market cap has decreased by -6.04% in one year.
Market Cap
495.10M
Enterprise Value
640.04M
1-Year Change
-6.04%
Ranking
Category
Stock Price
$7.50
ChartMarket Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $495.10M, a decrease of -33.93%. That is a compound annual growth rate of -3.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 495.10M | -32.09% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 519.99M |
| Allogene Therapeutics | 518.24M |
| Neurogene | 513.29M |
| Entera Bio | 495.19M |
| Contineum Therapeutics | 493.59M |
| Puma Biotechnology | 490.91M |
| Bright Minds Biosciences | 488.45M |
| Arvinas | 484.51M |